|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：D194920 |
| 產(chǎn)品名稱：Darapladib |
| 產(chǎn)品CAS：356057-34-6 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
D194920 |
| 名稱: |
Darapladib |
| 別名: |
N-[2-(Diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1H-cyclopentapyrimidine-1-acetamide; 1-[[[N-[2-(Diethylamino)ethyl]-N-[4-[4-(trifluoromethyl)phenyl]benzyl]amino]carbonyl]methyl]-2-(4-fluorobenzylthio)-5,6-trimethylenepyrimidin-4-one; SB 435445; SB 480848 |
| CAS號: |
356057-34-6 |
| 分子式: |
C??H??F?N?O?S |
| 分子量: |
666.77 |
| 種類: |
Research Tools; |
| 應(yīng)用: |
Darapladib (SB-480848) is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. |
| 參考文獻 |
|
|
|
|
?您的位置：
